Therefore, our systematic review and meta-analysis aim to shed light on the prevalence of HER2-low expression in Hispanic/Latino women with BC, a crucial step in understanding the molecular subtypes and potential treatment strategies for this population. Here, ERBB2 is linked to breast cancer.